NATERA, INC. Proceeds from Lines of Credit
NATERA, INC. (NTRA) reported Proceeds from Lines of Credit of $80.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2025-02-28
- NATERA, INC. proceeds from lines of credit for the quarter ending 2023-09-30 was $0.00.
- NATERA, INC. proceeds from lines of credit for the quarter ending 2023-06-30 was $0.00.
- NATERA, INC. proceeds from lines of credit for the quarter ending 2023-03-31 was $80.00M.
- NATERA, INC. proceeds from lines of credit for the quarter ending 2016-12-31 was $0.00.
- NATERA, INC. proceeds from lines of credit for fiscal 2022 was $30.00M.
- NATERA, INC. proceeds from lines of credit for fiscal 2016 was $8.00M.
| Period end | Proceeds from Lines of Credit 0 month | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $80.00M 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $80.00M 10-Q · filed 2023-08-04 | |||
| 2023-03-31 | $80.00M 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | $30.00M 10-K · filed 2025-02-28 | ||||
| 2022-11-08 | $30.00M 10-Q · filed 2023-11-09 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $8.00M 10-K · filed 2019-03-15 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $8.00M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $8.00M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |